Controversial Alzheimer’s drug approval sparks surprising impact
Drug slows Alzheimer’s but can it make a real difference?
30 November 2022Sunny with a chance of trauma: CT scans spike in hot weather
30 November 2022Controversial Alzheimer’s drug approval sparks surprising impact
When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer’s drug in nearly 20 years, it had a surprising impact on attitudes about research into the disease. A survey by University of California, Irvine neuroscientists has found news coverage of the FDA’s decision made the public less willing to volunteer for Alzheimer’s pharmaceutical trials.
